Usana Health Sciences annual operating margin
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Usana Health Sciences's operating margin was 4.05% for fiscal 2025.
View full Usana Health Sciences company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2026-01-03 | 4.05% | −3.72 pp |
| 2024 | 2024-12-28 | 7.76% | −2.34 pp |
| 2023 | 2023-12-30 | 10.11% | −0.67 pp |
| 2022 | 2022-12-31 | 10.78% | −3.57 pp |
| 2021 | 2022-01-01 | 14.34% | −1.21 pp |
| 2020 | 2021-01-02 | 15.55% | +1.77 pp |
| 2019 | 2019-12-28 | 13.78% | −2.06 pp |
| 2018 | 2018-12-29 | 15.84% | +3.19 pp |
| 2017 | 2017-12-30 | 12.65% | −1.13 pp |
| 2016 | 2016-12-31 | 13.78% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-07-04 | −8.96% | −16.04 pp |
| Q1 2026 | 2026-04-04 | 5.54% | −0.74 pp |
| Q4 2025 | 2026-01-03 | 1.69% | −2.16 pp |
| Q3 2025 | 2025-09-27 | 0.57% | −7.22 pp |
| Q2 2025 | 2025-06-28 | 7.09% | −1.29 pp |
| Q1 2025 | 2025-03-29 | 6.28% | −4.55 pp |
| Q4 2024 | 2024-12-28 | 3.84% | −7.11 pp |
| Q3 2024 | 2024-09-28 | 7.79% | −0.46 pp |
| Q2 2024 | 2024-06-29 | 8.38% | −1.86 pp |
| Q1 2024 | 2024-03-30 | 10.83% | +0.02 pp |
| Q4 2023 | 2023-12-30 | 10.95% | +1.06 pp |
| Q3 2023 | 2023-09-30 | 8.25% | −1.45 pp |
| Q2 2023 | 2023-07-01 | 10.24% | −0.86 pp |
| Q1 2023 | 2023-04-01 | 10.81% | −1.31 pp |
| Q4 2022 | 2022-12-31 | 9.89% | −1.89 pp |
| Q3 2022 | 2022-10-01 | 9.70% | −5.16 pp |
| Q2 2022 | 2022-07-02 | 11.10% | −4.84 pp |
| Q1 2022 | 2022-04-02 | 12.12% | −2.23 pp |
| Q4 2021 | 2022-01-01 | 11.79% | −5.13 pp |
| Q3 2021 | 2021-10-02 | 14.86% | −0.33 pp |
| Q2 2021 | 2021-07-03 | 15.95% | +0.66 pp |
| Q1 2021 | 2021-04-03 | 14.35% | −0.28 pp |
| Q4 2020 | 2021-01-02 | 16.92% | +0.49 pp |
| Q3 2020 | 2020-09-26 | 15.19% | +1.59 pp |
| Q2 2020 | 2020-06-27 | 15.28% | +3.11 pp |
| Q1 2020 | 2020-03-28 | 14.63% | +1.81 pp |
| Q4 2019 | 2019-12-28 | 16.43% | +0.19 pp |
| Q3 2019 | 2019-09-28 | 13.61% | −1.73 pp |
| Q2 2019 | 2019-06-29 | 12.17% | −4.79 pp |
| Q1 2019 | 2019-03-30 | 12.82% | −1.95 pp |
| Q4 2018 | 2018-12-29 | 16.24% | +4.26 pp |
| Q3 2018 | 2018-09-29 | 15.34% | +2.75 pp |
| Q2 2018 | 2018-06-30 | 16.96% | — |
| Q1 2018 | 2018-03-31 | 14.77% | — |
| Q3 2017 | 2017-09-30 | 11.98% | — |
| Q2 2017 | 2017-07-01 | 12.59% | — |
Over the last five reported fiscal years, Usana Health Sciences's operating margin decreased from 15.55% to 4.05%, a change of −11.51 percentage points. The latest reported quarter, Q2 2026, shows −8.96%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Usana Health Sciences filings at SEC.gov ↗